TotalMarketCap

Intercure

INCRNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$49.437 M

$3.30 -8.98%

Close of 6 Nov 2026

As of 6 Nov 2026, Intercure (INCR) has a market capitalization of $49.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

54,681,335

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #335Pliant TherapeuticsPLRX$50.5M
  2. #336ApollomicsAPLM$49.5M
  3. #337IntercureINCR$49.4M
  4. #338Werewolf TherapeuticsHOWL$49.3M
  5. #339OS TherapiesOSTX$47.9M

What if Intercure were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,881,986

Per share 571,164× higher

Bitcoin $1.53T

$101,830.97

Per share 30,905× higher

Apple $5.02T

$334,301.56

Per share 101,457× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Intercure are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.